330 related articles for article (PubMed ID: 17889104)
21. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
22. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
[TBL] [Abstract][Full Text] [Related]
23. Impact of donor/recipient traits independent of rejection on long-term renal function.
Kouli F; Morrell CH; Ratner LE; Kraus ES
Am J Kidney Dis; 2001 Feb; 37(2):356-65. PubMed ID: 11157378
[TBL] [Abstract][Full Text] [Related]
24. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
[TBL] [Abstract][Full Text] [Related]
25. Significant decrease in glomerular filtration rate at 5 years posttransplantation in the recipients of live donor kidneys 50 years of age or older.
Jain N; Airy M; Kumari P; Hull D; Ranga KV
Transplant Proc; 2010 Jun; 42(5):1648-53. PubMed ID: 20620493
[TBL] [Abstract][Full Text] [Related]
26. Arteriolar hyalinization in implantation kidney biopsies as a predictor of graft function.
Wazna E; Pazik J; Perkowska-Ptasińska A; Lewandowski Z; Nazarewski S; Chmura A; Durlik M
Transplant Proc; 2009 Oct; 41(8):2975-7. PubMed ID: 19857654
[TBL] [Abstract][Full Text] [Related]
27. Single versus dual renal transplantation from donors with significant arteriosclerosis on pre-implant biopsy.
Kayler LK; Mohanka R; Basu A; Shapiro R; Randhawa PS
Clin Transplant; 2009; 23(4):525-31. PubMed ID: 19681976
[TBL] [Abstract][Full Text] [Related]
28. Histologic assessment of donor kidneys and graft outcome: multivariate analyses.
Arias LF; Blanco J; Sanchez-Fructuoso A; Prats D; Duque E; Sáiz-Pardo M; Ruiz J; Barrientos A
Transplant Proc; 2007 Jun; 39(5):1368-70. PubMed ID: 17580141
[TBL] [Abstract][Full Text] [Related]
29. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
[TBL] [Abstract][Full Text] [Related]
30. Kidneys from deceased donors more than 75 years perform acceptably after transplantation.
Foss A; Heldal K; Scott H; Foss S; Leivestad T; Jørgensen PF; Scholz T; Midtvedt K
Transplantation; 2009 May; 87(10):1437-41. PubMed ID: 19461478
[TBL] [Abstract][Full Text] [Related]
31. Importance of renal mass on graft function outcome after 12 months of living donor kidney transplantation.
Douverny JB; Baptista-Silva JC; Pestana JO; Sesso R
Nephrol Dial Transplant; 2007 Dec; 22(12):3646-51. PubMed ID: 17704114
[TBL] [Abstract][Full Text] [Related]
32. In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function.
Dikow R; Becker LE; Schaier M; Waldherr R; Gross ML; Zeier M
Transplantation; 2010 Oct; 90(7):771-6. PubMed ID: 20697328
[TBL] [Abstract][Full Text] [Related]
33. [Limited prognostic value of surgical biopsy before transplantation of good quality renal transplants].
Neuzillet Y; Luccioni A; Daniel L; Lay F; Nahon O; Lechevallier E; Berland Y; Coulange C
Prog Urol; 2004 Feb; 14(1):24-8. PubMed ID: 15098747
[TBL] [Abstract][Full Text] [Related]
34. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection?
Dimény E; Wahlberg J; Larsson E; Fellström B
Clin Transplant; 1995 Apr; 9(2):79-84. PubMed ID: 7599406
[TBL] [Abstract][Full Text] [Related]
35. Cystatin C as a marker of renal function in kidney transplant patients.
Mendiluce A; Bustamante J; Martin D; Santos M; Bustamante R; Pascual P; Jabary NS; Castañeda A; Muñoz MA
Transplant Proc; 2005 Nov; 37(9):3844-7. PubMed ID: 16386559
[TBL] [Abstract][Full Text] [Related]
36. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit.
Blasi-Ibanez A; Hirose R; Feiner J; Freise C; Stock PG; Roberts JP; Niemann CU
Anesthesiology; 2009 Feb; 110(2):333-41. PubMed ID: 19194160
[TBL] [Abstract][Full Text] [Related]
37. Factors of impact on graft function at 2 years after transplantation in living-donor kidney transplantation: a single-center study in china.
Zhao J; Song WL; Mo CB; Wang ZP; Fu YX; Feng G; Zheng JM; Shen ZY
Transplant Proc; 2011 Dec; 43(10):3690-3. PubMed ID: 22172827
[TBL] [Abstract][Full Text] [Related]
38. Association between preoperative allograft function (effective renal plasma flow) and the change in glomerular filtration rate among living-donor kidney transplant recipients.
Chang SS; Hung CJ; Lin YJ; Chou TC; Chung PY; Lin YS; Lee PC
Transplant Proc; 2012 Jan; 44(1):248-53. PubMed ID: 22310624
[TBL] [Abstract][Full Text] [Related]
39. Recovery of graft function early posttransplant determines long-term graft survival in deceased donor renal transplants.
Hassanain M; Tchervenkov JI; Cantarovich M; Metrakos P; Paraskevas S; Keith D; Baran D; Fernandez M; Mangel R; Chaudhury P
Transplant Proc; 2009; 41(1):124-6. PubMed ID: 19249494
[TBL] [Abstract][Full Text] [Related]
40. Independent risk factors and natural history of renal dysfunction in liver transplant recipients.
Pawarode A; Fine DM; Thuluvath PJ
Liver Transpl; 2003 Jul; 9(7):741-7. PubMed ID: 12827563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
